interleukin-4 (PanGen Biotech)

N/A

Report date: 2025/03/20 15:37:24

Base Information

Drug Nameinterleukin-4 (PanGen Biotech)
Drug Alias NameIL-4 (PanGen Biotech)interleukin-4IL-4
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionInterleukin-4 receptor subunit alpha agonists
TargetsInterleukin-4 receptor subunit alpha
Therapy Area/IndicationsLymphoma, Non-HodgkinHodgkin DiseaseLeukemia, Lymphocytic, Chronic, B-Cell
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesPangen Biotech
China Registration ClassN/A

Develop Information

Active CompaniesPangen Biotech
Inactive CompaniesN/A
Active IndicationsLymphoma, Non-HodgkinHodgkin DiseaseLeukemia, Lymphocytic, Chronic, B-Cell
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A